NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

India's Rising Liver Disease Burden: A Financial Shock

India is facing a growing crisis of liver-related conditions, with Nonalcoholic Fatty Liver Disease affecting between 9 percent and 32 percent of the population. Despite policy efforts, financial preparedness at the household level remains weak, and treatment costs are climbing. According to the Ministry of Health and Family Welfare, liver-related medical conditions already contribute to over 66 percent of total deaths, and rising treatment costs are making them an increasing financial burden.

The Gap in Insurance Coverage

The biggest gap appears at the beginning of the disease journey, where early-stage fatty liver is usually managed through consultations, tests, and medication. These fall under outpatient care, which most standard health insurance plans do not cover. Patients often spend between Rs 30,000 and Rs 60,000 annually, entirely from their own pockets.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Insurance PolicyOutpatient Care Coverage
Standard PlanNo coverage
Preventive Check-up PlanLimited coverage
Add-on PlanFull coverage

Even when the disease progresses to a stage that requires hospitalisation, coverage is not always straightforward. Insurers do pay for hospital stays, but having a policy can sharply reduce payouts. Room rent limits are a common example, where insurers may apply proportionate deductions across the entire bill. In practical terms, a hospital bill of Rs 2.5 lakh could see only half reimbursed, leaving families to absorb the rest.

Transplants: High Cover, but Still Shortfalls

At the severe end of the spectrum lies liver transplantation, often the only option for survival. These procedures can cost between Rs 20 lakh and Rs 25 lakh. While many health insurance policies today offer high sum insured options, coverage gaps remain. Donor-related expenses, which are essential to the procedure, are often capped or partially covered. This can leave families facing a shortfall of Rs 2 lakh to Rs 5 lakh even after exhausting their insurance cover.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

The Overlooked Burden after Surgery

The financial strain does not end with a successful transplant. In fact, one of the most significant blind spots in health insurance is post-transplant care. Patients require lifelong medication and regular follow-ups to prevent organ rejection. These costs, often around Rs 15,000 per month or roughly Rs 1.8 lakh a year, are typically not covered under standard policies.

Experts' Warning

Experts note that while hospitalisation, diagnostics, and critical illness benefits may be included, the exact scope varies widely among insurers, making it crucial for policyholders to read the policy terms carefully. The widening gap between the rising number of liver disease cases and limited insurance coverage is becoming harder to ignore. While insurers are gradually expanding offerings, experts say consumers must pay closer attention to policy details, add-ons, and exclusions.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.